Neptune Wellness Solutions, Inc.

As of July 8, 2024, Neptune Wellness Solutions, Inc. is considered overvalued with deteriorating financial metrics, including a negative P/E ratio and EV to EBITDA, despite a recent stock surge, indicating a bleak long-term outlook.

As of October 1, 2023, Neptune Wellness Solutions, Inc. is considered attractive and undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.1, especially compared to peers like Canopy Growth and Tilray, while also outperforming the Sensex.

As of October 5, 2023, there is not enough technical data on Neptune Wellness Solutions, Inc. to determine if it is bullish or bearish.

As of March 2022, the management team of Neptune Wellness Solutions, Inc. includes Mr. John Moretz as Independent Chairman, Mr. Michael Cammarata as President and CEO, and several Independent Directors: Mr. Joseph Buaron, Mr. Michael De Geus, Dr. Ronald Denis, and Mr. Richard Schottenfeld.

As of March 2023, Neptune Wellness Solutions, Inc. has an unavailable market capitalization, reported net sales of 39.12 million, a net loss of 78.82 million, negative shareholder funds of -11.94 million, and total assets of 30.93 million.